Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M.


Autoria(s): Scherrer A.U.; von Wyl V.; Götte M.; Klimkait T.; Cellerai C.; Yerly S.; Böni J.; Held L.; Ledergerber B.; Günthard H.F.; Swiss HIV Cohort Study
Data(s)

2012

Resumo

BACKGROUND: We hypothesized that polymorphic mutations exist that are associated with the emergence of the multinucleoside resistance mutations (MNR), 69 insertion and Q151M. METHODS: The Swiss HIV Cohort Study was screened, and the frequencies of polymorphic mutations in HIV-1 (subtype B) were compared between patients detected with the 69 insertion (n = 17), Q151M (n = 29), ≥2 thymidine analogue mutations (TAM) 1 (n = 400) or ≥2 TAM 2 (n = 249). Logistic regressions adjusted for the antiretroviral treatment history were performed to analyze the association of the polymorphic mutations with MNR. RESULTS: The 69 insertion and TAM 1 were strongly associated and occurred in 94.1% (16 of 17) together. The 69 insertion seemed to emerge as a consequence of the TAM 1 pathway (median years until detection: 6.8 compared with 4.4 for ≥2 TAM 1, P Wilcoxon = 0.009). Frequencies of 8 polymorphic mutations (K43E, V60I, S68G, S162C, T165I, I202V, R211K, F214L) were significantly different between groups. Logistic regression showed that F214L and V60I were associated with the emergence of Q151M/TAM 2 opposed to 69 insertion/TAM 1. S68G, T165I, and I202V were associated with Q151M instead of TAM 2. CONCLUSIONS: Besides antiretroviral therapy, polymorphic mutations may contribute to the emergence of specific MNR mutations.

Identificador

http://serval.unil.ch/?id=serval:BIB_9C1A5E8F92FD

isbn:1944-7884 (Electronic)

pmid:22027876

doi:10.1097/QAI.0b013e31823c8b69

isiid:000299789600006

Idioma(s)

en

Fonte

Journal of Acquired Immune Deficiency Syndromes, vol. 59, no. 2, pp. 105-112

Palavras-Chave #Amino Acid Substitution/genetics; Anti-HIV Agents/pharmacology; Cohort Studies; Drug Resistance, Multiple, Viral/genetics; Gene Frequency; HIV Infections/drug therapy; HIV Infections/genetics; HIV Reverse Transcriptase/genetics; HIV-1/drug effects; HIV-1/genetics; Humans; Logistic Models; Mutagenesis, Insertional; Mutation; Nucleosides/genetics; Switzerland; Thymidine/analogs & derivatives; Thymidine/genetics
Tipo

info:eu-repo/semantics/article

article